FDA NDC Directory · JSON-LD · Markdown

Nintedanib esylate

NDC 33342-551 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerMacleods Pharmaceuticals Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA219926
Dosage form / routeCAPSULE · ORAL
Active ingredientsNINTEDANIB ESYLATE (150 mg/1)
Marketing started20260803
Package count1

External sources

Source: openFDA. Public-domain (CC0).